jcm-logo

Journal Browser

Journal Browser

Bleeding and Thrombotic Complications in Patients with Premalignant Hematologic Conditions: Diagnostic and Therapeutic Challenges

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Hematology".

Deadline for manuscript submissions: 20 February 2026 | Viewed by 17

Special Issue Editors


E-Mail
Guest Editor
Hematology Department, Alexandra General Hospital, Athens, Greece
Interests: platelet biology; platelet immunology; hypercogulability; thrombosis; bleeding; disorders of hemostasis; antithrombotics
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Alexandra Hospital, Department of Clinical Therapeutics, University of Athens, 80 Vasilissis Sofias Avenue, 11528 Athens, Greece
Interests: multiple myeloma; AL amyloidosis; plasma cell dyscrasias; monoclonal gammopathies
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue is dedicated to highlighting recent advances and challenges in the field of thrombotic and bleeding complications in otherwise asymptomatic individuals with premalignant hematologic conditions characterized by clonal hematopoiesis of myeloid or lymphoid origin. Special focus will be given to emerging data indicating a cross-talk of hemostasis with monoclonal gammopathy of undetermined significance, monoclonal B-cell lymphocytosis, and clonal hematopoiesis.

These conditions are increasingly recognized for their association not only with progression to overt malignancy, but also with vascular complications. Recent evidence has drawn attention to newly recognized thrombogenic entities, grouped under the term monoclonal gammopathy of thrombotic significance, including VITT-like syndrome. Moreover, the link between somatic mutations in genes commonly associated with myeloid neoplasms identified in individuals without overt disease or cardiovascular risk raises important clinical questions that are currently under active debate. Bleeding risk appears to be a less recognized complication that may be overlooked in clinical practice.

This issue aims to foster dialogue between researchers and clinicians, encouraging multidisciplinary collaboration in this rapidly evolving field.

You may choose our Joint Special Issue in Hematology Reports.

Dr. Vasiliki Gkalea
Dr. Despina Fotiou
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bleeding
  • thrombosis
  • hematologic malignancies
  • premalignant hematologic conditions
  • clonal hematopoiesis of indeterminate potential (CHIP)
  • clonal cytopenias of undetermined significance (CCUS)
  • monoclonal gammopathy of undetermined significance (MGUS)
  • monoclonal B-cell lymphocytosis (MBL)
  • monoclonal gammopathy of thrombotic significance (MGTS)
  • VITT-like MGTS

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop